Author:
Elnady Rana E.,Amin Maha M.,Zakaria Mohamed Y.
Abstract
AbstractInfectious and cancerous diseases are tedious to manage. The problem of drug resistance is often associated with anti-microbial and anti-cancer agents and is one of the most significant challenges that restrict their activity. Therefore, it is necessary to increase doses or drug combinations. However, introducing drugs in this way is often ineffective due to poor solubility, low bioavailability, reduced stability, and different drug pharmacokinetic parameters. Vesicular nanocarriers are considered promising for effective drug delivery and overcoming drug resistance. Lipid-based drug delivery systems (LBDDS) such as emulsomes (EMLs) can solve many problems associated with drug physicochemical properties. EMLs share structural similarities with liposomes and solid lipid nanoparticles (SLNs). The main components of emulsomal preparation are triglycerides (TG), phospholipids (PC), and cholesterol (Chol). These systems provide greater stability and pharmacokinetic parameters in vivo compared to liposomes and other lipid-based systems, overcoming their limitations and surpassing their shortcomings. This review offers a broad summary of emulsomal research to date and a comprehensive overview of the formulation materials and their effects on the fabrication, physical characteristics, surface modification, lymphatic targeting, and recent applications of EMLs in infectious and cancerous diseases. EMLs can offer stable and safe lipid-based systems with adequate entrapment and sustained release properties, improving bioavailability and evading multidrug resistance. Furthermore, they hold promise for future clinical applications for anti-microbial and anti-cancer drugs.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Abedini E, Khodadadi E, Zeinalzadeh E, Moaddab SR, Asgharzadeh M, Mehramouz B, Dao S, Kafil HS (2021) A comprehensive study on the antimicrobial properties of resveratrol as an alternative therapy. Hindawi 2021:15
2. Abo El-Enin HA, Mostafa RE, Ahmed MF, Naguib IA, Abdelgawad MA, Ghoneim MM, Abdou EM (2022) Assessment of nasal-brain-targeting efficiency of new developed mucoadhesive emulsomes encapsulating an anti-migraine drug for effective treatment of one of the major psychiatric disorders symptoms. Pharmaceutics 14:410
3. Akbarzadeh A, Rezaei-sadabady R, Davaran S, Joo SW, Zarghami N (2013) Liposome : classification, prepNew aspects of liposomesaration, and applications. Nanoscale Res Lett 8:1–9
4. Aldawsari HM, Ahmed OAA, Alhakamy NA, Neamatallah T, Fahmy UA, Badr-Eldin SM (2021) Lipidic nano-sized emulsomes potentiates the cytotoxic and apoptotic effects of raloxifene hydrochloride in mcf-7 human breast cancer cells: factorial analysis and in vitro anti-tumor activity assessment. Pharmaceutics 13:783
5. Alhakamy NA, Badr-Eldin SM, Ahmed OAA et al (2020) Piceatannol-loaded emulsomes exhibit enhanced cytostatic and apoptotic activities in colon cancer cells. Antioxidants 9:419
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献